CTLA4 and cancer: Furthermore, T cell activity is hindered owing to the expression of tumor-suppressive molecules such as PD-L1 and PD-L2 on cancer cells and CTLA-4 and PD-1 on T cells, which camouflage tumor cells from the immune system, and ultimately limit anticancer immunity.